275 related articles for article (PubMed ID: 25363101)
1. Risperidone versus risperidone plus sodium valproate for treatment of bipolar disorders: a randomized, double-blind clinical-trial.
Moosavi SM; Ahmadi M; Monajemi MB
Glob J Health Sci; 2014 Jul; 6(6):163-7. PubMed ID: 25363101
[TBL] [Abstract][Full Text] [Related]
2. Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety.
Sachs GS; Grossman F; Ghaemi SN; Okamoto A; Bowden CL
Am J Psychiatry; 2002 Jul; 159(7):1146-54. PubMed ID: 12091192
[TBL] [Abstract][Full Text] [Related]
3. Risperidone adjunctive therapy duration in the maintenance treatment of bipolar I disorder: A post hoc analysis.
Valdes M; Bertolin S; Qian H; Wong H; Lam RW; Yatham LN
J Affect Disord; 2019 Mar; 246():861-866. PubMed ID: 30795492
[TBL] [Abstract][Full Text] [Related]
4. Risperidone plus lithium versus risperidone plus valproate in acute and continuation treatment of mania.
Yatham LN; Binder C; Kusumakar V; Riccardelli R
Int Clin Psychopharmacol; 2004 Mar; 19(2):103-9. PubMed ID: 15076019
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of combination of risperidone and haloperidol with divalproate in patients with acute mania.
Ouyang WC; Hsu MC; Yeh IN; Kuo CC
Int J Psychiatry Clin Pract; 2012 Sep; 16(3):178-88. PubMed ID: 22404731
[TBL] [Abstract][Full Text] [Related]
6. Risperidone does not affect steady-state pharmacokinetics of divalproex sodium in patients with bipolar disorder.
Ravindran A; Silverstone P; Lacroix D; van Schaick E; Vermeulen A; Alexander J
Clin Pharmacokinet; 2004; 43(11):733-40. PubMed ID: 15301577
[TBL] [Abstract][Full Text] [Related]
7. A randomized, double-blind, placebo-controlled study of maintenance treatment with adjunctive risperidone long-acting therapy in patients with bipolar I disorder who relapse frequently.
Macfadden W; Alphs L; Haskins JT; Turner N; Turkoz I; Bossie C; Kujawa M; Mahmoud R
Bipolar Disord; 2009 Dec; 11(8):827-39. PubMed ID: 19922552
[TBL] [Abstract][Full Text] [Related]
8. One-year rehospitalization rates of patients with first-episode bipolar mania receiving lithium or valproate and adjunctive atypical antipsychotics.
Woo YS; Bahk WM; Jung YE; Jeong JH; Lee HB; Won SH; Lee KH; Jon DI; Yoon BH; Kim MD; Min KJ
Psychiatry Clin Neurosci; 2014 Jun; 68(6):418-24. PubMed ID: 24506520
[TBL] [Abstract][Full Text] [Related]
9. Risperidone for the treatment of acute mania in children and adolescents with bipolar disorder: a randomized, double-blind, placebo-controlled study.
Haas M; Delbello MP; Pandina G; Kushner S; Van Hove I; Augustyns I; Quiroz J; Kusumakar V
Bipolar Disord; 2009 Nov; 11(7):687-700. PubMed ID: 19839994
[TBL] [Abstract][Full Text] [Related]
10. Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind study.
Vieta E; Owen R; Baudelet C; McQuade RD; Sanchez R; Marcus RN
Curr Med Res Opin; 2010 Jun; 26(6):1485-96. PubMed ID: 20429835
[TBL] [Abstract][Full Text] [Related]
11. Open-label prospective trial of risperidone in combination with lithium or divalproex sodium in pediatric mania.
Pavuluri MN; Henry DB; Carbray JA; Sampson G; Naylor MW; Janicak PG
J Affect Disord; 2004 Oct; 82 Suppl 1():S103-11. PubMed ID: 15571784
[TBL] [Abstract][Full Text] [Related]
12. A randomized, double-blind, placebo-controlled trial to assess prevention of mood episodes with risperidone long-acting injectable in patients with bipolar I disorder.
Vieta E; Montgomery S; Sulaiman AH; Cordoba R; Huberlant B; Martinez L; Schreiner A
Eur Neuropsychopharmacol; 2012 Nov; 22(11):825-35. PubMed ID: 22503488
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of aripiprazole adjunctive to lithium or valproate in the long-term treatment of patients with bipolar I disorder with an inadequate response to lithium or valproate monotherapy: a multicenter, double-blind, randomized study.
Marcus R; Khan A; Rollin L; Morris B; Timko K; Carson W; Sanchez R
Bipolar Disord; 2011 Mar; 13(2):133-44. PubMed ID: 21443567
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study.
Salloum IM; Cornelius JR; Daley DC; Kirisci L; Himmelhoch JM; Thase ME
Arch Gen Psychiatry; 2005 Jan; 62(1):37-45. PubMed ID: 15630071
[TBL] [Abstract][Full Text] [Related]
15. Risperidone in the treatment of mixed state bipolar patients: results from a 24-week, multicenter, open-label study in Korea.
Woo YS; Bahk WM; Jon DI; Chung SK; Lee SY; Ahn YM; Pae CU; Cho HS; Kim JG; Hwang TY; Lee HS; Min KJ; Lee KU; Yoon BH
Psychiatry Clin Neurosci; 2010 Feb; 64(1):28-37. PubMed ID: 19895394
[TBL] [Abstract][Full Text] [Related]
16. Risperidone treatment of bipolar mania.
Nguyen LN; Guthrie SK
Ann Pharmacother; 2006 Apr; 40(4):674-82. PubMed ID: 16569811
[TBL] [Abstract][Full Text] [Related]
17. A mood stabilizer with risperidone or haloperidol for mania.
Andrade C
Am J Psychiatry; 2004 Nov; 161(11):2140. PubMed ID: 15514435
[No Abstract] [Full Text] [Related]
18. Lurasidone as adjunctive therapy with lithium or valproate for the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study.
Loebel A; Cucchiaro J; Silva R; Kroger H; Sarma K; Xu J; Calabrese JR
Am J Psychiatry; 2014 Feb; 171(2):169-77. PubMed ID: 24170221
[TBL] [Abstract][Full Text] [Related]
19. Rates of remission/euthymia with quetiapine in combination with lithium/divalproex for the treatment of acute mania.
Sussman N; Mullen J; Paulsson B; Vågerö M
J Affect Disord; 2007; 100 Suppl 1():S55-63. PubMed ID: 17383736
[TBL] [Abstract][Full Text] [Related]
20. Rapid antimanic effect of risperidone monotherapy: a 3-week multicenter, double-blind, placebo-controlled trial.
Hirschfeld RM; Keck PE; Kramer M; Karcher K; Canuso C; Eerdekens M; Grossman F
Am J Psychiatry; 2004 Jun; 161(6):1057-65. PubMed ID: 15169694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
